These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34356280)

  • 1. Tumor Characteristic Variations between Symptomatic and Asymptomatic Endometrial Cancer.
    Vinklerová P; Bednaříková M; Minář L; Felsinger M; Hausnerová J; Ovesná P; Weinberger V
    Healthcare (Basel); 2021 Jul; 9(7):. PubMed ID: 34356280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.
    van der Putten LJM; Visser NCM; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MPLM; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Werner HMJ; Amant F; Massuger LFAG; Pijnenborg JMA
    Int J Gynecol Cancer; 2018 Mar; 28(3):514-523. PubMed ID: 29324536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers.
    Weinberger V; Bednarikova M; Hausnerova J; Ovesna P; Vinklerova P; Minar L; Felsinger M; Jandakova E; Cihalova M; Zikan M
    Front Oncol; 2019; 9():265. PubMed ID: 31032226
    [No Abstract]   [Full Text] [Related]  

  • 4. Preoperative Magnetic Resonance Volumetry in Predicting Myometrial Invasion, Lymphovascular Space Invasion, and Tumor Grade: Is It Valuable in International Federation of Gynecology and Obstetrics Stage I Endometrial Cancer?
    Sahin H; Sarioglu FC; Bagci M; Karadeniz T; Uluer H; Sanci M
    Int J Gynecol Cancer; 2018 May; 28(4):666-674. PubMed ID: 29697491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification.
    Karnezis AN; Leung S; Magrill J; McConechy MK; Yang W; Chow C; Kobel M; Lee CH; Huntsman DG; Talhouk A; Kommoss F; Gilks CB; McAlpine JN
    J Pathol Clin Res; 2017 Oct; 3(4):279-293. PubMed ID: 29085668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting sonographic preoperative local staging of endometrial cancer.
    Fischerova D; Frühauf F; Zikan M; Pinkavova I; Kocián R; Dundr P; Nemejcova K; Dusek L; Cibula D
    Ultrasound Obstet Gynecol; 2014 May; 43(5):575-85. PubMed ID: 24281994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
    Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
    J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma].
    Li M; Wang Z; Zhao L; Li X; Wang J; Zhang C; Wei L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):455-9. PubMed ID: 25169640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.
    Padilla-Iserte P; Lago V; Tauste C; Díaz-Feijoo B; Gil-Moreno A; Oliver R; Coronado P; Martín-Salamanca MB; Pantoja-Garrido M; Marcos-Sanmartin J; Gilabert-Estellés J; Lorenzo C; Cazorla E; Roldán-Rivas F; Rodríguez-Hernández JR; Sánchez L; Muruzábal JC; Hervas D; Domingo S;
    Am J Obstet Gynecol; 2021 Jan; 224(1):65.e1-65.e11. PubMed ID: 32693096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
    Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
    Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
    Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
    Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
    de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
    PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the finding of endometrial hyperplasia or corporal polyp an mandatory indication for biopsy?
    Vinklerová P; Felsinger M; Frydová S; Ovesná P; Hausnerová J; Weinberger V
    Ceska Gynekol; 2020; 85(2):84-93. PubMed ID: 32527101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
    Li M; Zhao L; Shen D; Li X; Wang J; Wei L
    Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preponderance of endometrial carcinoma in elderly patients.
    Ogane N; Hori SI; Yano M; Katoh T; Kamoshida S; Kato H; Kameda Y; Yasuda M
    Mol Clin Oncol; 2018 Sep; 9(3):269-273. PubMed ID: 30155248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.